✦ LIBER ✦

Platform Presentation—Dimebon in Mild-to-Moderate Huntington's Disease: A Multicenter, Phase 2, Randomized, Placebo-Controlled Trial (DIMOND)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S3-02-03: Results of a one-year randomiz

✍ Rachelle S. Doody; Svetlana Gavrilova; Mary Sano; Ronald Thomas; Paul Aisen; Ser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Study of the ketogenic agent AC-1202 in

✍ Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; La 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 640 KB

Results from CONNECTION: A global, Phase

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Masitinib as an adjunct therapy for mild

✍ François Piette, Joël Belmin, Hélène Vincent… 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 349 KB

Saffron in the treatment of patients wit

✍ S. Akhondzadeh; M. Shafiee Sabet; M. H. Harirchian; M. Togha; H. Cheraghmakani; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Intravenous immunoglobulin for treatment

✍ Dodel, Richard; Rominger, Axel; Bartenstein, Peter; Barkhof, Frederik; Blennow, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 746 KB